ESMO Immuno-Oncology Virtual Congress 2020

9-12 December 2020

Lugano, Switzerland, 30 November 2020 – The ESMO Immuno-Oncology Congress 2020, the European platform dedicated to the development and use of immunotherapies for cancer treatment, will be held as a virtual meeting. (1)

The Scientific programme will provide a comprehensive overview of cancer treatment, from the basics of immunotherapies to the latest research results, and from the understanding of the different treatment options to the management of toxicities and interpretation of new data. (2)

Programme highlights

    – Future of adjuvant and neoadjuvant treatment

    – Tumour microenvironment

    – Development of novel therapeutics in preclinical and early stages

    – Interfaces between COVID-19 and immunotherapy in cancer patients

    – Updates and novel data in gastrointestinal, lung, breast and gynecological cancers

ESMO welcomes media interested in reporting from the ESMO events and on cancer issues. Only through the official accreditation process with the ESMO Media Registration Form, accredited media representatives will be able to access scientific and educational sessions (live streamed and on-demand), live Q&A with invited speakers and e-poster presenters, e-posters, virtual exhibition and industry satellite symposia, Congress webcasts.? (3)

Further information

ESMO Press Office

[email protected]

References

(1) ESMO Immuno-Oncology Virtual Congress 2020 https://www.esmo.org/meetings/esmo-immuno-oncology-virtual-congress-2020

(2) Scientific programme https://cslide.ctimeetingtech.com/immuno2020v/attendee/confcal/session/calendar

(3) Media Registration Form https://esmo.formstack.com/forms/media_registration_form_immuno_oncology2020

Notes to Editors

Please make sure to use the official name of the meeting in your reports: ESMO Immuno-Oncology Virtual Congress 2020

Official Congress hashtag: #ESMOImmuno20

About the European Society for Medical Oncology (ESMO)

ESMO is the leading professional organisation for medical oncology. With more than 25,000 members representing oncology professionals from over 160 countries worldwide, ESMO is the society of reference for oncology education and information. ESMO is committed to offer the best care to people with cancer, through fostering integrated cancer care, supporting oncologists in their professional development, and advocating for sustainable cancer care worldwide. Visit http://www.esmo.org

###

Media Contact
ESMO Press Office
[email protected]

Comments